Search Results
10
Everything
Porsche AG records robust results in a challenging environment
March 12, 2025 06:58 ET
|
Porsche Cars North America, Inc.
Stuttgart., March 12, 2025 (GLOBE NEWSWIRE) -- Robust 2024 financial year: Group sales revenue of 40.1 billion euros, Group Operating profit of 5.6 billion euros, Group operating return on sales...
Philips publishes its Annual Report 2024
February 21, 2025 06:45 ET
|
Royal Philips
February 21, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2024. Philips’ Annual Report 2024 will be...
Philips delivers growth, improved profitability, and strong cash flow in Q4 and 2024; continues solid execution of its three-year plan
February 19, 2025 01:00 ET
|
Royal Philips
February 19, 2025Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit...
CSX Corp. Announces Fourth Quarter and Full Year 2024 Results
January 23, 2025 16:02 ET
|
CSX Corporation
JACKSONVILLE, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced fourth quarter 2024 operating income of $1.11 billion compared to $1.32 billion in the prior year...
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024 09:30 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.
Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
October 28, 2024 02:00 ET
|
Royal Philips
October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by...
Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
August 16, 2024 09:00 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA
Philips to repurchase shares for up to EUR 125 million to cover long-term incentive plans
August 05, 2024 06:00 ET
|
Royal Philips
August 5, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase shares for an amount of up to EUR 125 million to cover certain of its...
Philips delivers strong order intake growth in the second quarter, margin improvement and sales growth; reiterates full-year outlook
July 29, 2024 01:00 ET
|
Royal Philips
July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2%Comparable order intake increased by 9%Income from operations EUR 816...
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity